Cytomatrix Limited is a limited by shares Australian public company. Located at VIC 3207 since 2015-09-11 the company is, as the updated on 2021-12-13 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2004-07-13. Known company numbers for Cytomatrix Limited are as follows: ACN - 109903737, Australian Business Number - 69109903737. Cytomatrix Limited has been the company name since 2014-09-19. Cytomatrix Pty Ltd is one of the trading names this company has used, to be precise, the trading names list includes 1 position that is Cytomatrix Pty Ltd since 2004-07-13. Their official company name changed on 2004-07-13 to Cytomatrix Pty Ltd. The company had used this name up until 2014-09-19. This Australian public company was previously located in VIC 3220 (from 2014-06-04 to 2015-09-11), VIC 3220 (from 2009-05-29 to 2014-06-04), VIC 3000 (from 2006-09-05 to 2009-05-29).
Status | From | To |
---|---|---|
Active | 2004-07-13 | current |
Name | From | To |
---|---|---|
Cytomatrix Limited | 2014-09-19 | current |
Cytomatrix Pty. Ltd. | 2004-07-13 | 2014-09-19 |
Name | From | To |
---|---|---|
Cytomatrix Pty Ltd | 2004-07-13 | current |
Location | From | To |
---|---|---|
VIC 3207 | 2015-09-11 | current |
VIC 3220 | 2014-06-04 | 2015-09-11 |
VIC 3220 | 2009-05-29 | 2014-06-04 |
VIC 3000 | 2006-09-05 | 2009-05-29 |
VIC 3000 | 2006-09-04 | 2006-09-05 |
VIC 3000 | 2004-07-13 | 2006-09-04 |
Status | From | To |
---|---|---|
Registered | 2004-07-13 | current |
Advertisements
General information:
Patent status: |
Filed The specification prior to acceptance and where the application has not lapsed |
Patent type: | NPE |
International Patent Classification:
IPC Mark: | C12N 5/0789 |
Section code: | C - chemistrymetallurgy |
Class code: | 12 - biochemistry; beer; spirits; wine; vinegar; microbiology; enzymology; mutation or genetic engineering |
Subclass code: | N - micro-organisms or enzymes; compositions thereof (biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, enzymes, fermentates, or substances produced by, or extracted from, micro-organisms or animal material a01n0063000000; medicinal preparations a61k; fertilisers c05f); propagating, preserving, or maintaining micro-organisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) |
Main group code: | 5 - undifferentiated human, animal or plant cells, e.g. cell lines; tissues; cultivation or maintenance thereof; culture media therefor (plant reproduction by tissue culture techniques a01h0004000000) |
Subgroup code: | 789 - stem cells; multipotent progenitor cells |
IP Australia process information:
Expiry date: | 2032-09-21 |
General information:
Patent status: |
Lapsed Either the application has not been accepted by 21 months after the first examination report (or 12 months after the Raising the Bar Act) or some other deadline in the prosecution process has not been completed in time, for example IP Australia has issued a direction to file a request for examination and the applicant has not done so in the required period (2 months). |
Patent type: | NPE |
International Patent Classification:
IPC Mark: | C12N 15/07 |
Section code: | C - chemistrymetallurgy |
Class code: | 12 - biochemistry; beer; spirits; wine; vinegar; microbiology; enzymology; mutation or genetic engineering |
Subclass code: | N - micro-organisms or enzymes; compositions thereof (biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, enzymes, fermentates, or substances produced by, or extracted from, micro-organisms or animal material a01n0063000000; medicinal preparations a61k; fertilisers c05f); propagating, preserving, or maintaining micro-organisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) |
Main group code: | 15 - mutation or genetic engineering; dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; use of hosts therefor (mutants or genetically engineered micro-organisms c12n0001000000, c12n0005000000, c12n0007000000; new plants a01h; plant reproduction by tissue culture techniques a01h0004000000; new animals a01k0067000000; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy a61k0048000000; peptides in general c07k) |
Subgroup code: | 7 - human cells |
IP Australia process information:
Expiry date: | 2028-11-28 |
General information:
Patent status: |
Lapsed Either the application has not been accepted by 21 months after the first examination report (or 12 months after the Raising the Bar Act) or some other deadline in the prosecution process has not been completed in time, for example IP Australia has issued a direction to file a request for examination and the applicant has not done so in the required period (2 months). |
Patent type: | NPE |
International Patent Classification:
IPC Mark: | A61K 38/17 |
Section code: | A - human necessities |
Class code: | 61 - medical or veterinary science; hygiene |
Subclass code: | K - preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l) |
Main group code: | 38 - medicinal preparations containing peptides (peptides containing beta-lactam rings a61k0031000000; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, a61k0031000000; ergoline-based peptides a61k0031480000; containing macromolecular compounds having statistically distributed amino acid units a61k0031740000; medicinal preparations containing antigens or antibodies a61k0039000000; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, a61k0047000000) |
Subgroup code: | 17 - from animals; from humans |
IP Australia process information:
Expiry date: | 2028-06-13 |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.